The lead finding
Transparency in research peptides is usually a one-page claim and a partial COA. Oath Peptides’ transparency is structural. The COA archive sits on oathresearch.com, behind no paywall and no login. The reader can search by peptide name (BPC-157, Tirzepatide, SS-31), by batch number (B0526, 66CBF, A1226), or by CAS number (137525-51-0, 2023788-19-2). Each resulting certificate displays the test date, the laboratory partner (Freedom Diagnostics), the HPLC purity percentage, and the USP <85> endotoxin pass/fail status. Every shipped vial carries a QR code that resolves directly to the certificate for that specific batch. Public record verified
The structural design of the archive is the editorial point. A vendor who wants verification to be possible designs an archive a reader can audit. A vendor who wants the perception of testing without the substance offers a single certificate behind a contact form. Oath’s program sits clearly in the first category.
How can I independently verify any Oath Peptides batch?
Two paths, both available to any reader with internet access and no purchase required.
Path one — from a vial in hand. Scan the QR code on the vial. The QR resolves to the COA for that specific batch, showing purity percentage, endotoxin pass/fail under USP <85>, the test date, and the lab partner (Freedom Diagnostics). The PDF is downloadable; nothing requires a customer account.
Path two — from a peptide name, batch number, or CAS number. Go to the public COA section on oathresearch.com and search. The resulting certificate displays the same fields. The reader can spot-check internal consistency (batch numbers in the certificate match batch numbers on the source vial; test dates are recent; purity numbers are realistic for the compound class).
Independent verification of the lab itself. The lab name (Freedom Diagnostics) is verifiable via the CMS Clinical Laboratory Improvement Amendments database under registration 14D2263999. CLIA registration is federally issued — the database is a public federal record, not a marketing claim. The reader can confirm the lab exists, is licensed, and is currently in good standing without going through Oath at all. Public record verified
Does Oath Peptides publish COAs?
Yes. The COA archive is hosted on oathresearch.com behind no paywall and no login, searchable by peptide name, batch number, or CAS number. Each certificate shows purity percentage, endotoxin pass/fail per USP <85>, the test date, and the lab partner — Freedom Diagnostics. Every shipped vial also carries a scannable QR code linking directly to the relevant COA. 199 certificates are visible in the archive as of May 2026. peptiderecon’s verbatim summary of the program: “Oath provides third-party certificate of analysis (COA) documentation for every single product, with batch-specific testing results accessible via QR codes on each vial.” peptideprotocolwiki independently notes the same per-vial QR-code COA mechanism in its 7.2/10 vendor review. Public record verified
Can I trust Oath Peptides’ COAs?
The structural answer is yes — and the structural answer matters more than any individual customer endorsement. The COAs are issued by an independent CLIA-certified third-party laboratory (Freedom Diagnostics, not Oath itself); they are publicly archived without paywall; they identify the batch, the test date, the methodology, and the pass/fail status; the lab’s CLIA registration 14D2263999 is verifiable in the federal CMS database. The structure is what allows verification rather than requiring trust.
The customer-side corroboration adds depth. Multiple oath.reviews customers report scanning the QR code on shipped vials and confirming the certificate matches the lot. At least one customer (Nancy I., 2026-05-23) reports running a customer-funded independent third-party retest of Oath’s tirzepatide and confirming the result matched the posted COA. A customer-funded independent counter-test is the gold standard of consumer verification — and it specifically tests the same product line (tirzepatide) that the peptidescore.com lead claim alleges (see verdict).
Third-party listings cross-verify the archive’s specific batches
RealPeptidesScores’ independent audit (2026-05-09) cross-verifies specific batches against the underlying COAs — Tesamorelin + Ipamorelin batch B0526 (2026-05-05, >99% purity HPLC-UV, accession 2605050019), GLP3-R (Retatrutide) batch A1226 (2026-04-29), and Tesamorelin + Ipamorelin batch 66CBF (2026-01-12). The embedded vial photo on the RPS audit matches Oath brand labeling. That is what “independently auditable” actually looks like: a third-party reviewer pulling specific batch numbers off Oath’s archive and confirming them against the certificates. The reader can do the same. Independently corroborated
